Postmenopausal Period Clinical Trial
Official title:
Efficacy and Safety of HPC-03(Extracts of Angelica Gigas Nakai, Cnidium Rhizome, and Cinnamon Bark) for Postmenopausal Symptom
In women, as the age increases, ovarian function is lost, resulting in the deficiency of
female hormones, resulting in menopause, in which menstruation is permanently lost. The
average age of menopause in Korean women is 49.7 years old, which is equivalent to 22.3% of
the total female population. In addition, the increase in the number of women who experience
early menopause due to environmental factors such as stress as a result of the increase in
the number of women entering the society is also a major cause of the expansion of the
market for menopausal women's health functional foods. Women's menopausal symptoms have been
regarded as a natural process for everyone, but with the recent interest in health and the
results of related studies, the perception that menopausal symptom management is necessary
has spread.
In traditional medicine of far east asia, danggui (Angelica gigas Nakai), taeunggung
(Cnidium Rhizome), and broilers (Cinnamon bark) have been commonly used for postmenopausal
symptoms improvement. However, scientific evidence for these foods are lacking. Therefore,
in this study the investigators tried to examine the efficacy and safety of extracts of
angelica gigas nakai, cnidium rhizome, and cinnamon bark in postmenopausal symptoms. This
study is designed as double-blinded placebo control study.
The results of preclinical efficacy evaluation of HPC-03 (Angelica gigas Nakai complex
extract) obtained by mixing materials mentioned above showed that increase of serum estrogen
level and increase of bone mineral density (BMD) of femur due to ALP(Alkaline phosphatase )
inhibition, bone related index (BALP,bone-specific alkaline phosphatase ; CTX- 1,C-terminal
telopeptide-1 ; Osteocalcin).
Therefore, the investigators aimed to confirm the safety and efficacy of HPC-03 (a complex
extract of Angelica gigas Nakai) which has been confirmed in preclinical studies, on the
improvement of menopausal symptoms.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04735549 -
Vulvovaginal Atrophy Correction Using Neodymium Laser
|
N/A | |
| Completed |
NCT01064453 -
Angeliq Regulatory Post Marketing Surveillance
|
N/A | |
| Completed |
NCT05483413 -
The Effect of Progressive Relaxation Exercises on Sleep Quality and Fatigue in Postmenopausal Period
|
N/A | |
| Completed |
NCT05463081 -
Clinical Trial of "Magic Gyno" Laser Device
|
N/A | |
| Recruiting |
NCT05335317 -
Treatment of Vaginal Atrophy With Low Intensity Nanosecond Neodymium Laser
|
N/A |